🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Rationale Acute ischemic stroke due to atrial fibrillation (AF) carries a h...
Status
Completed
Location
Asan Medical Center
Start Date
2014-01
Trial ID
NCT02042534
Treatments Being Tested
The purpose of this study is to test any good and bad effects of the study ...
Status
Active Not Recruiting
Location
Hartford Healthcare Cancer Institute @ Hartford Hospital
Start Date
2016-10
Trial ID
NCT02921022
Treatments Being Tested
Atrial fibrillation (AF) coincides with coronary artery disease (CAD) share...
Status
Recruiting
Location
Ling Tao
Start Date
2022-09-01
Trial ID
NCT05353140
Treatments Being Tested
This study is a randomized, single-blind, placebo-controlled study to asses...
Status
Completed
Location
Frontage Clinical Services Inc.
Start Date
2017-05-08
Trial ID
NCT03172910
Treatments Being Tested
Evaluation of 2 doses of rivaroxaban (10 and 15 mg) compared to dual anti p...
Status
Completed
Location
Institut de Cardiologie - Hôpital Pitié-Salpêtrière
Start Date
2017-09-13
Trial ID
NCT03273322
Treatments Being Tested
1. The recent development of novel oral anticoagulants (NOACs), including d...
Status
Unknown
Location
National Cheng Kung University Hospital
Start Date
2016-01
Trial ID
NCT02666157
Treatments Being Tested
The aim of this study is to investigate the efficacy and safety of rivaroxa...
Status
Completed
Location
Kantonsspital Baden
Start Date
2018-07-19
Trial ID
NCT03522259
Treatments Being Tested
The increased risk of Atrial fibrillation (AF) regarding thromboembolic str...
Status
Recruiting
Location
Ling Tao
Start Date
2023-07-06
Trial ID
NCT05960721
Treatments Being Tested
The study is designed to compare the efficacy and safety of oral rivaroxaba...
Status
Completed
Location
Capital Medical Unvierstiy Cancer Center/ Beijing Shijitan Hospital
Start Date
2016-02-16
Trial ID
NCT03282643
Treatments Being Tested